These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 12185508
1. Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia. Goetz M, Behre G, Heussel G, Steinmetz HT, Eigler A, Hiddemann W, Weiss M. Ann Hematol; 2002 Jul; 81(7):382-5. PubMed ID: 12185508 [Abstract] [Full Text] [Related]
2. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia. Goetz M, Schiel X, Heussel H, Steinmetz T, Hiddemann W, Weiss M. Eur J Med Res; 2002 Nov 25; 7(11):487-90. PubMed ID: 12568977 [Abstract] [Full Text] [Related]
3. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients. Jabłońska E, Pietruska Z. Arch Immunol Ther Exp (Warsz); 1997 Nov 25; 45(5-6):449-53. PubMed ID: 9437501 [Abstract] [Full Text] [Related]
4. sTNF-RII: is it useful for the early diagnosis of rejection and for prognosis after renal transplantation? Diller R, Winde G, Kötting S, Senninger N, Dietl KH, Spiegel HU. Transpl Int; 2002 Jul 25; 15(7):335-40. PubMed ID: 12122509 [Abstract] [Full Text] [Related]
5. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Glossop JR, Dawes PT, Nixon NB, Mattey DL. Arthritis Res Ther; 2005 Jul 25; 7(6):R1227-34. PubMed ID: 16277675 [Abstract] [Full Text] [Related]
6. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia. Schmid I, Schmitt M, Streiter M, Meilbeck R, Haas RJ, Stachel DK. Eur J Med Res; 2005 Nov 16; 10(11):457-61. PubMed ID: 16354598 [Abstract] [Full Text] [Related]
7. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis]. Zhang D, Li J, Jiang Z, Yu B, Tang X. Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1529-31. PubMed ID: 12609060 [Abstract] [Full Text] [Related]
8. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia]. Shen R, Xu CG, Li LZ, Zhang T, Qin XM, Li J, Zhao CL. Zhonghua Xue Ye Xue Za Zhi; 2004 Apr 25; 25(4):209-12. PubMed ID: 15182557 [Abstract] [Full Text] [Related]
9. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Iglesias J, Marik PE, Levine JS, Norasept II Study Investigators. Am J Kidney Dis; 2003 Jan 25; 41(1):62-75. PubMed ID: 12500222 [Abstract] [Full Text] [Related]
10. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma. Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S, Kanemura N, Yamada T, Shimizu M, Takahashi T, Tomita E, Seishima M, Takami T, Moriwaki H. Eur J Haematol; 2006 Sep 25; 77(3):217-25. PubMed ID: 16856931 [Abstract] [Full Text] [Related]
11. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode]. Gómez Roca C, Rivero M, Hugo K, Novillo A, Marta Lapadula M, Recondo G, Milberg M. Medicina (B Aires); 2006 Sep 25; 66(5):385-91. PubMed ID: 17137166 [Abstract] [Full Text] [Related]
12. Poly-C specific ribonuclease activity correlates with increased concentrations of IL-6, IL-8 and sTNFR55/sTNFR75 in plasma of patients with acute pancreatitis. Naskalski JW, Kusnierz-Cabala B, Panek J, Kedra B. J Physiol Pharmacol; 2003 Sep 25; 54(3):439-48. PubMed ID: 14566081 [Abstract] [Full Text] [Related]
13. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications. Engel A, Knoll S, Kern P, Kern WV. Infection; 2005 Oct 25; 33(5-6):380-2. PubMed ID: 16258872 [Abstract] [Full Text] [Related]
14. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer. Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A. Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769 [Abstract] [Full Text] [Related]
15. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M. J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529 [Abstract] [Full Text] [Related]
16. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial. Harter C, Schulze B, Goldschmidt H, Benner A, Geiss HK, Hoppe-Tichy T, Ho AD, Egerer G. Bone Marrow Transplant; 2006 Feb 01; 37(4):373-9. PubMed ID: 16400334 [Abstract] [Full Text] [Related]
17. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City]. Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A. Rev Invest Clin; 2006 Feb 01; 58(6):547-54. PubMed ID: 17432285 [Abstract] [Full Text] [Related]
18. Fever and sepsis during neutropenia are associated with expansion of extracellular and loss of intracellular water. Schwenk A, Schlottmann S, Kremer G, Diehl V, Salzberger B, Ward L. Clin Nutr; 2000 Feb 01; 19(1):35-41. PubMed ID: 10700532 [Abstract] [Full Text] [Related]
19. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y. Metabolism; 2005 Oct 01; 54(10):1297-301. PubMed ID: 16154427 [Abstract] [Full Text] [Related]
20. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B. Serwin AB, Wasowicz W, Chodynicka B. Nutrition; 2006 Sep 01; 22(9):860-4. PubMed ID: 16829029 [Abstract] [Full Text] [Related] Page: [Next] [New Search]